Prebiotic Effect of Fructooligosaccharides from <i>Morinda officinalis</i> on Alzheimer's Disease in Rodent Models by Targeting the Microbiota-Gut-Brain Axis.
Ontology highlight
ABSTRACT: Gut microbiota influences the central nervous system disorders such as Alzheimer's disease (AD). The prebiotics and probiotics can improve the host cognition. A previous study demonstrated that fructooligosaccharides from Morinda officinalis (OMO) exert effective memory improvements in AD-like animals, thereby considered as potential prebiotics; however, the underlying mechanism still remains enigma. Thus, the present study investigated whether OMO is effective in alleviating AD by targeting the microbiota-gut-brain axis. OMO was administered in rats with AD-like symptoms (D-galactose- and Aβ1-42-induced deficient rats). Significant and systematic deterioration in AD-like animals were identified, including learning and memory abilities, histological changes, production of
SUBMITTER: Chen D
PROVIDER: S-EPMC5727096 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
ACCESS DATA